36,813 Shares in Astera Labs, Inc. (NASDAQ:ALAB) Purchased by Gunderson Capital Management Inc.

Gunderson Capital Management Inc. purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 36,813 shares of the company's stock, valued at approximately $4,876,000. Astera Labs makes up about 2.4% of Gunderson Capital Management Inc.'s investment portfolio, making the stock its 17th biggest holding.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Tidal Investments LLC boosted its stake in shares of Astera Labs by 81.8% in the 3rd quarter. Tidal Investments LLC now owns 45,298 shares of the company's stock valued at $2,373,000 after purchasing an additional 20,388 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Astera Labs in the third quarter valued at approximately $530,000. Avior Wealth Management LLC bought a new stake in shares of Astera Labs during the third quarter worth $361,000. Maverick Capital Ltd. increased its holdings in shares of Astera Labs by 16.0% during the third quarter. Maverick Capital Ltd. now owns 1,156,230 shares of the company's stock worth $60,575,000 after buying an additional 159,480 shares in the last quarter. Finally, State Street Corp lifted its stake in shares of Astera Labs by 173.1% in the 3rd quarter. State Street Corp now owns 698,467 shares of the company's stock valued at $36,593,000 after acquiring an additional 442,698 shares during the last quarter. Institutional investors own 60.47% of the company's stock.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB traded up $1.26 during mid-day trading on Tuesday, hitting $128.45. The company had a trading volume of 2,702,041 shares, compared to its average volume of 3,220,390. The firm has a fifty day moving average price of $116.88 and a 200 day moving average price of $74.77. Astera Labs, Inc. has a one year low of $36.22 and a one year high of $147.39.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.23 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.06. The company had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The firm's revenue was up 47.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that Astera Labs, Inc. will post -0.45 EPS for the current year.

Insider Transactions at Astera Labs

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 50,000 shares of the company's stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $89.70, for a total value of $4,485,000.00. Following the completion of the sale, the director now directly owns 129,617 shares of the company's stock, valued at approximately $11,626,644.90. This represents a 27.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Manuel Alba sold 11,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $117.50, for a total transaction of $1,292,500.00. Following the transaction, the director now directly owns 456,863 shares in the company, valued at approximately $53,681,402.50. This represents a 2.35 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,690,452 shares of company stock valued at $167,581,256 over the last three months.

Analyst Upgrades and Downgrades

ALAB has been the subject of several research reports. Needham & Company LLC reiterated a "buy" rating and issued a $65.00 target price on shares of Astera Labs in a research report on Wednesday, October 9th. Morgan Stanley raised their price objective on shares of Astera Labs from $94.00 to $142.00 and gave the company an "overweight" rating in a report on Friday, December 20th. Northland Capmk lowered shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Thursday, January 2nd. Roth Mkm raised their price target on shares of Astera Labs from $80.00 to $105.00 and gave the company a "buy" rating in a research note on Tuesday, November 5th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Astera Labs from $70.00 to $110.00 and gave the stock an "overweight" rating in a report on Tuesday, November 5th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $105.75.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.